DSPE-PEG2000-Azide ammonium
Based on 1 Customer Validation
DSPE-PEG2000-Azide ammonium is an azide-functionalized phospholipid and lipid-polyethylene glycol conjugate. DSPE-PEG2000-Azide ammonium serves as a component of azide-functionalized liposome nanoparticles, which enables conjugation with DBCO-modified antibodies and proteins via strain-promoted alkyne-azide cycloaddition, and can also passively insert into exosome membranes through hydrophobic interactions, thereby achieving modular surface engineering via azide-alkyne click chemistry. DSPE-PEG-Azide ammonium binds to bovine milk exosomes with a KD of 347 μM.
For research use only. We do not sell to patients.
- Purity: 99.9%
- CAS No.: 1938081-40-3
- Formula: (C2H4O)nC44H84N4O10P.NH4
-
Storage:
-20°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Biological Activity
DSPE-PEG2000-Azide ammonium-containing liposomes successfully conjugate with DBCO-modified antibodies and SOD via strain-promoted alkyne-azide cycloaddition, producing purified immunoliposomes with ~50 antibodies per liposome and no detectable size change[1].
DSPE-PEG2000-Azide ammonium stably inserts into the lipid bilayer of bovine milk exosomes via hydrophobic interaction, incorporating ~394 PEG chains per exosome at a 20000:1 molar ratio, modifying surface charge without altering particle size, and remaining stable in PBS and mucin environments[2].
DSPE-PEG2000-Azide ammonium modified bovine milk exosomes exhibit significantly enhanced stability in acidic buffers mimicking gastric conditions, with half the protein loss of unmodified exosomes at pH 2.2 and pH 4.5[2].
DSPE-PEG2000-Azide ammonium modified bovine milk exosomes exhibit 3.2-fold enhanced permeability across an in vitro intestinal mucus layer compared to unmodified exosomes[2].
DSPE-PEG2000-Azide ammonium modified bovine milk exosomes loaded with GFP-targeting siRNA mediate 60% silencing of GFP expression in HEK293 cells, with only slightly reduced efficacy compared to unmodified siRNA-loaded exosomes[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 1938081-40-3
-
Appearance Solid
-
Formula (C2H4O)nC44H84N4O10P.NH4
-
Color White to light yellow
-
SMILES
CCCCCCCCCCCCCCCCCC(OCC(COP([O-])(OCCNC(OCCOCCN=[N+]=[N-])=O)=O)OC(CCCCCCCCCCCCCCCCC)=O)=O.[n].[NH4+]
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
-20°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Purity & Documentation
-
Data Sheet (268 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
References
[1]. Reyes-Esteves S, et al. Targeted drug delivery to the brain endothelium dominates over passive delivery via vascular leak in experimental intracerebral hemorrhage. Journal of controlled release : official journal of the Controlled Release Society. 2023 Apr;356:185-195. [Content Brief]
[2]. Warren MR, et al. Milk exosomes with enhanced mucus penetrability for oral delivery of siRNA. Biomaterials science. 2021 Jun 15;9(12):4260-4277. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
- DSPE-PEG2000-Azide
- 1938081-40-3
- Biochemical Assay Reagents
- Liposome
- strain-promoted alkyne-azide cycloaddition
- HEK293 cells
- lipid-polyethylene glycol conjugate
- azide-functionalized liposomal nanoparticles
- intracerebral hemorrhage
- brain endothelial cells
- phospholipid
- exosome membranes
- DBCO-modified antibodies
- bovine milk exosomes
- Inhibitor
- inhibitor
- inhibit